These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18032706)

  • 1. Lentiviral (HIV)-based RNA interference screen in human B-cell receptor regulatory networks reveals MCL1-induced oncogenic pathways.
    Ruiz-Vela A; Aggarwal M; de la Cueva P; Treda C; Herreros B; Martín-Pérez D; Dominguez O; Piris MA
    Blood; 2008 Feb; 111(3):1665-76. PubMed ID: 18032706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
    Schwickart M; Huang X; Lill JR; Liu J; Ferrando R; French DM; Maecker H; O'Rourke K; Bazan F; Eastham-Anderson J; Yue P; Dornan D; Huang DC; Dixit VM
    Nature; 2010 Jan; 463(7277):103-7. PubMed ID: 20023629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
    Longo PG; Laurenti L; Gobessi S; Sica S; Leone G; Efremov DG
    Blood; 2008 Jan; 111(2):846-55. PubMed ID: 17928528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins.
    Tabrizi SJ; Niiro H; Masui M; Yoshimoto G; Iino T; Kikushige Y; Wakasaki T; Baba E; Shimoda S; Miyamoto T; Hara T; Akashi K
    J Immunol; 2009 Feb; 182(3):1490-9. PubMed ID: 19155496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
    Kozopas KM; Yang T; Buchan HL; Zhou P; Craig RW
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3516-20. PubMed ID: 7682708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Expression of Bcl-2 Family Proteins Determines the Sensitivity of Human Follicular Lymphoma Cells to Dexamethasone-mediated and Anti-BCR-mediated Apoptosis.
    Adem J; Ropponen A; Eeva J; Eray M; Nuutinen U; Pelkonen J
    J Immunother; 2016 Jan; 39(1):8-14. PubMed ID: 26641257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation.
    Huskey NE; Guo T; Evason KJ; Momcilovic O; Pardo D; Creasman KJ; Judson RL; Blelloch R; Oakes SA; Hebrok M; Goga A
    Stem Cell Reports; 2015 Mar; 4(3):374-89. PubMed ID: 25733019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells.
    De Biasio A; Vrana JA; Zhou P; Qian L; Bieszczad CK; Braley KE; Domina AM; Weintraub SJ; Neveu JM; Lane WS; Craig RW
    J Biol Chem; 2007 Aug; 282(33):23919-36. PubMed ID: 17561513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C.
    Townsend KJ; Trusty JL; Traupman MA; Eastman A; Craig RW
    Oncogene; 1998 Sep; 17(10):1223-34. PubMed ID: 9771965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents.
    Vrana JA; Cleaveland ES; Eastman A; Craig RW
    Apoptosis; 2006 Aug; 11(8):1275-88. PubMed ID: 16761109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis.
    Okamoto T; Coultas L; Metcalf D; van Delft MF; Glaser SP; Takiguchi M; Strasser A; Bouillet P; Adams JM; Huang DC
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):261-6. PubMed ID: 24363325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma.
    Zhu L; Somlo G; Zhou B; Shao J; Bedell V; Slovak ML; Liu X; Luo J; Yen Y
    Mol Cancer Ther; 2005 May; 4(5):787-98. PubMed ID: 15897243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells.
    Inoue C; Sobue S; Kawamoto Y; Nishizawa Y; Ichihara M; Abe A; Hayakawa F; Suzuki M; Nozawa Y; Murate T
    Biochem Biophys Res Commun; 2020 May; 525(4):1074-1080. PubMed ID: 32184020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors.
    Labisso WL; Wirth M; Stojanovic N; Stauber RH; Schnieke A; Schmid RM; Krämer OH; Saur D; Schneider G
    Cell Cycle; 2012 Apr; 11(8):1593-602. PubMed ID: 22456335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical genomics identifies small-molecule MCL1 repressors and BCL-xL as a predictor of MCL1 dependency.
    Wei G; Margolin AA; Haery L; Brown E; Cucolo L; Julian B; Shehata S; Kung AL; Beroukhim R; Golub TR
    Cancer Cell; 2012 Apr; 21(4):547-62. PubMed ID: 22516262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression data.
    Schrader A; Meyer K; Walther N; Stolz A; Feist M; Hand E; von Bonin F; Evers M; Kohler C; Shirneshan K; Vockerodt M; Klapper W; Szczepanowski M; Murray PG; Bastians H; Trümper L; Spang R; Kube D
    Oncotarget; 2016 Jul; 7(30):47061-47081. PubMed ID: 27166259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of BCL2 family member MCL1 as an early response to DNA damage.
    Zhan Q; Bieszczad CK; Bae I; Fornace AJ; Craig RW
    Oncogene; 1997 Mar; 14(9):1031-9. PubMed ID: 9070651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
    Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
    Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of molecular vulnerabilities in human multiple myeloma cells by RNA interference lethality screening of the druggable genome.
    Tiedemann RE; Zhu YX; Schmidt J; Shi CX; Sereduk C; Yin H; Mousses S; Stewart AK
    Cancer Res; 2012 Feb; 72(3):757-68. PubMed ID: 22147262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.